1. Introduction {#sec0005}
===============

Glomus tumour (GT) is a neoplastic lesion of mesenchymal origin arising from the neuromyoarterial canal or glomus body. Although most glomus tumours occur in the peripheral soft tissue and extremities, these tumours can grow anywhere in the body [@bib0005]. Stomach is a common extracutaneous site of glomus tumour and constitute about 1% of gastric mesenchymal tumours [@bib0010]. Only few cases have been reported after its first description by key et al. in 1951 [@bib0015]. The histopathology examination using conventional techniques of staining often does not allow for accurate diagnosis, making the use of immunohistochemistry an indispensable tool to confirm the diagnosis of glomus tumour [@bib0020].

2. Presentation of case {#sec0010}
=======================

A 32 year old female presented to surgical out-patient department with epigastric pain for two months.. Endoscopy revealed a polypoidal mass of size 3 × 2 cm with intact mucosa in anterior wall of gastric antrum. ([Fig. 1](#fig0005){ref-type="fig"}).

Contrast enhanced Computer tomography(CECT) of abdomen showed a lobulated heterogeneously enhanching mass of size 3 × 2 cm in antral region of stomach and protruding into its lumen. It does not extend beyond the stomach wall into the surrounding structures and no enlarged lymph nodes. ([Fig. 2](#fig0010){ref-type="fig"}).

Wedge resection of tumour was done([Fig. 3](#fig0015){ref-type="fig"}a and b). Gross examination reveals a solitary grey white firm tumour mass ([Fig. 3](#fig0015){ref-type="fig"}c) confirming the submucosal location.

Microscopic examination reveals solid proliferation of tumour cells around blood vessels in the submucosa and the muscular layer. The mucosa is intact. The tumour cells are round to oval with scanty cytoplasm with round nucleus and incospicous nucleoli. Mitosis is less than 1/50HPF. The diagnosis of small round cell tumour was made. The probable differential diagnosis were glomus tumour, carcinoid tumour, gastro intestinal stromal tumour and lymphoma ([Fig. 4](#fig0020){ref-type="fig"} and [Table 1](#tbl0005){ref-type="table"}).
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3. Discussion {#sec0015}
=============

Gastric submucosal tumours (SMTs) represents non-epithelial mesenchymal neoplasms accounting for only 0.1--1% of all gastro intestinal tumours [@bib0025]. They arise from the submucosa or muscularis propria of the gastric wall and usually spare the overlying mucosa [@bib0030]. GIST is the most common submucosal tumour of the stomach, other submucosal tumours can be frequently mistaken for a GIST [@bib0035]. The frequency of gastric glomus tumours is estimated to be 100 times less than that of gastrointestinal stromal tumours (GIST). The prevalence of gastric GT is dominant in females in the fifth or sixth decade, but a wide range of ages has been encountered [@bib0005]. Gastric glomus tumours are most commonly described as solitary, well‑defined, submucosal lesions in the antrum, presenting with a variety of symptoms [@bib0005]. The most frequent complaints associated with gastric GT include epigastric pain, upper gastrointestinal bleeding and ulcerous syndrome with or without nausea or vomiting [@bib0005]. Due to the deep location of glomus tumour, preoperative diagnosis is difficult [@bib0015].

The main diagnostic modalities for evaluating SMTs are endoscopic ultrasound (EUS) and computed tomography (CT) [@bib0030]. The former has an advantage in identifying the layer of tumour origin, and the latter is advantageous in tumour characterization with the use of contrast enhancement [@bib0030]. EUS will show a hypoechoic, well-circumscribed mass located in the third and/or fourth EUS layer [@bib0035; @bib0040; @bib0045; @bib0050] EUS-guided biopsy is now a well established modality for sampling submucosal lesions [@bib0045; @bib0055].

Contrast enhanced Computer enhanced tomography these tumours demonstrate strong enhancement on arterial‑phase scans and persistent enhancement on portal venous‑phase scans [@bib0055]. Often confused with GIST, the distinguishing features are that the density of GISTs is lower than that of GTs, and GISTs do not exhibit prolonged enhancement in the delayed phase [@bib0045].

On, magnetic resonance images, gastric GT shows slightly hypointense on T1-weighted images and slightly hyperintense on T2-weighted images and is hypervascular and exhibits persistent enhancement after gadolinium administration [@bib0020].

Histologic features are central round to oval nuclei with inconspicuous nucleoli and clear to eosinophilic cytoplasm with distinct cell [@bib0045]. Immunohistochemistry is essential in the differential diagnosis of GT, and the immunohistochemical panel generally showed that GT tumour was strongly and diffusely positive for smooth muscle actin, vimentin and actin, calponin, type IV collagen, and laminin [@bib0020]. Glomus tumours are divided into solid glomus tumours, glomangioma and glomagiomyoma. our case is a glomangioma,which constitutes 20% of all glomus tumours [@bib0060].

Criteria for malignant glomus tumours of soft tissue proposed by Folpe et al. included: (a) Deep location and size \>2 cm or (b) atypical mitotic figure or (c) moderate to high nuclear grade and mitotic activity (5 mitoses/50HPF) [@bib0010; @bib0015]. There seems to be a marked difference in clinical course of glomus tumours in deep peripheral soft tissue and those in the stomach. For gastric glomus tumours, size \>5 cm is more important than the mitosis and atypia for assessing risk for malignancy [@bib0010].

Treatment of choice for gastric glomus tumour is wedge resection with negative margins [@bib0010; @bib0015; @bib0045; @bib0065]. Completely resected small tumours without necrosis and mitosis have good prognosis [@bib0010] ([Table 2](#tbl0010){ref-type="table"}).

4. Conclusion {#sec0020}
=============

Gastric glomus tumours are unusual distinct lesion that should be considered in the differential diagnosis of a gastric submucosal mass [@bib0030]. Immunohistochemical studies are helpful in the differential diagnosis of gastric glomus tumours,although most are benign, malignancy cannot be excluded. Thus,long-term follow --up of the patient is necessary [@bib0065].

![Polypoidal mass on endoscopy along greater curvature.](gr1){#fig0005}

![CECT abdomen showing a lobulated mass protruding into the lumen.](gr2){#fig0010}

![(a) antral mass along greater curvature (b) wedge resection of mass with staplers (c) resected specimen confirming the submucosal location.](gr3){#fig0015}

![(a) H&E showing solid sheets of tumour cells intervined by blood vessels of varying size (10X) (b) High Power showing cuffs of tumour cells around the blood vessels lined by flattened endothelial cells (40X).](gr4){#fig0020}

###### 

Immuno histochemistry was performed. The Immuno histochemical results are as follows.

  Pan CK                     Negative
  -------------------------- -------------------
  CK 7                       Negative
  Ki-67                      \<1 per 50 hpf
  CD 117/C-kit               Negative
  Leucocyte Common Antigen   Negative
  Vimentin                   Strongly positive
  Smooth muscle actin        Strongly positive
  CD 31                      Negative
  CD 34                      Focally positive
  Chromogranin               Negative
  Synaptophysin              Weak positive

The tumour cells showed a strong reactivity for vimentin and smooth muscle actin confirming the diagnosis of Glomus tumour.

###### 

Differential diagnosis of gastric glomus includes Carcinoid tumours, Epitheloid variant of GIST, and Lymphoma [@bib0005; @bib0010; @bib0020].

  ---------------------------------------------------------------------------------------------------
  Tumour type        SMA   Vimentin   CD 117   CD31 & CD 34   LCA   Pan CK & CK 7   Chromogranin &\
                                                                                    Synaptophysin
  ------------------ ----- ---------- -------- -------------- ----- --------------- -----------------
  Glomus Tumour      ++    ++         −        −              −     −               +/−

  GIST               +/−   \+         ++       −              −     +/−             −

  Carcinoid Tumour   −     −          −        −              −     \+              ++

  Gastric Lymphoma   −     −          −        −              \+    −               −
  ---------------------------------------------------------------------------------------------------

++ Strongly Positive; − Negative; +/− Weakly positive; / Negative.
